The Potential for Serum p53 to Predict the Response to Chemotherapy of Patients with Gastric Cancer

Author： Zhang J He X-H Xie X-Y Hu X He C

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.38, Iss.2, 2010-03, pp. : 423-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Correlation of Tissue p53 Protein Overexpression and p53 Antigen in Serum of Patients with Bladder Cancer

By Gopi Kishore M. Hamid Arif Dwivedi U.S. Tandon Vipul Mahmood Mufti Singh Harbans Singh P.B.

UroOncology, Vol. 2, Iss. 3, 2003-07 ,pp. : 121-128

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Using microarrays to predict resistance to chemotherapy in cancer patients

By Lee Chung-Hae Macgregor Pascale F

Pharmacogenomics, Vol. 5, Iss. 6, 2004-09 ,pp. : 611-625

Future Medicine

Access to resources Recommend Favorite

A deletion in chromosome 11q may predict the response to anthracycline-based chemotherapy in patients with early node-negative breast cancer

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Pretreatment platelet‐to‐lymphocyte ratio is associated with the response to first‐line chemotherapy and survival in patients with metastatic gastric cancer

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

p53: Fighting Cancer

Current Cancer Drug Targets, Vol. 4, Iss. 5, 2004-08 ,pp. : 385-402

Bentham Science Publishers

Access to resources Recommend Favorite